Holen Sie sich die Stockscreener-App
4.11
3.53%
0.14
Schlusskurs vom Vortag:
$3.97
Offen:
$4
24-Stunden-Volumen:
115.81K
Relative Volume:
0.56
Marktkapitalisierung:
$241.11M
Einnahmen:
$33.48M
Nettoeinkommen (Verlust:
$-52.70M
KGV:
-3.1888
EPS:
-1.2889
Netto-Cashflow:
$-49.45M
1W Leistung:
+0.24%
1M Leistung:
-3.75%
6M Leistung:
+9.89%
1J Leistung:
+50.00%
1-Tages-Spanne:
$4.00
$4.16
1-Wochen-Bereich:
$3.775
$4.16
52-Wochen-Spanne:
$2.20
$5.424
Orchestra Biomed Holdings Inc Stock (OBIO) Company Profile
Firmenname
Orchestra Biomed Holdings Inc
Sektor
Branche
Telefon
646-343-9298
Adresse
150 UNION SQUARE DRIVE, NEW HOPE
Compare OBIO vs VRTX, REGN, ARGX, ALNY, ONC
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
OBIO
Orchestra Biomed Holdings Inc
|
4.12 | 232.33M | 33.48M | -52.70M | -49.45M | -1.2889 |
VRTX
Vertex Pharmaceuticals Inc
|
427.39 | 107.83B | 12.07B | 3.95B | 3.19B | 15.33 |
REGN
Regeneron Pharmaceuticals Inc
|
707.48 | 73.54B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
803.58 | 48.72B | 4.16B | 1.29B | 734.26M | 19.58 |
ALNY
Alnylam Pharmaceuticals Inc
|
294.01 | 39.51B | 3.71B | 313.75M | 465.38M | 2.2571 |
ONC
Beone Medicines Ltd Adr
|
299.23 | 32.66B | 5.36B | 287.73M | 924.18M | 2.5229 |
Orchestra Biomed Holdings Inc Stock (OBIO) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-12-10 | Eingeleitet | TD Cowen | Buy |
| 2025-08-20 | Herabstufung | BTIG Research | Buy → Neutral |
| 2025-03-20 | Eingeleitet | BTIG Research | Buy |
| 2025-01-02 | Eingeleitet | Barclays | Overweight |
| 2024-08-22 | Eingeleitet | H.C. Wainwright | Buy |
| 2024-07-25 | Eingeleitet | B. Riley Securities | Buy |
| 2024-01-19 | Eingeleitet | Jefferies | Buy |
| 2023-02-24 | Eingeleitet | Piper Sandler | Overweight |
| 2023-02-07 | Eingeleitet | Chardan Capital Markets | Buy |
Alle ansehen
Orchestra Biomed Holdings Inc Aktie (OBIO) Neueste Nachrichten
FDA Grants Orchestra BioMed Additional Breakthrough Device Designation for AVIM Therapy - Investing News Network
Orchestra BioMed: RTW funds sell $132 in stock By Investing.com - Investing.com Canada
Orchestra BioMed: RTW funds sell $132 in stock - Investing.com
Orchestra BioMed (OBIO) stake rises to 19.2% after RTW warrant exercise - Stock Titan
RTW funds exercise 1.25M Orchestra BioMed (NASDAQ: OBIO) pre-funded warrants - Stock Titan
Orchestra BioMed (NASDAQ: OBIO) seeks ESPP, director votes at 2026 meeting - Stock Titan
BTIG Downgrades Orchestra BioMed Holdings (OBIO) - MSN
Orchestra BioMed Holdings (OBIO) price target decreased by 11.17% to 11.39 - MSN
Orchestra BioMed launches public offering; shares down 16% - MSN
Orchestra BioMed to Present AVIM Therapy Clinical and Mechanistic Data at HRS 2026 - Investing News Network
Orchestra BioMed Reports Positive Results from MODERATO II Trial for Atrioventricular Interval Modulation Therapy in Hypertension Management - Quiver Quantitative
Study data showed a 13.2 mmHg drop in systolic blood pressure with AVIM - Stock Titan
Orchestra BioMed Holdings, Inc. (NASDAQ:OBIO) Sees Large Growth in Short Interest - MarketBeat
Portfolio Update: Will Orchestra BioMed Holdings Inc benefit from geopolitical trends2026 Reactions & Smart Allocation Stock Tips - baoquankhu1.vn
If You Invested $1,000 in Orchestra BioMed Holdings Inc (OBIO) - Stock Titan
Orchestra BioMed Holdings, Inc. (NASDAQ:OBIO) Given Consensus Recommendation of "Moderate Buy" by Brokerages - MarketBeat
Gains Report: How much upside does Orchestra BioMed Holdings Inc haveMarket Growth Report & Real-Time Market Sentiment Reports - baoquankhu1.vn
OBIO Options Volatility — NASDAQ:OBIO - TradingView
OBIO Options Chain — NASDAQ:OBIO - TradingView
Is Orchestra (OBIO) Stock Ready to Drop | Price at $4.18, Down 1.18%Real Time Stock Idea Network - Cổng thông tin điện tử tỉnh Lào Cai
How sensitive is Orchestra BioMed Holdings Inc to inflation2026 Market Outlook & Verified High Yield Trade Plans - baoquankhu1.vn
Orchestra BioMed : April 2026 Corporate Presentation - marketscreener.com
Orchestra BioMed Holdings (OBIO) Stock Price Prediction: Today, Tomorrow, Next Week - Traders Union
Orchestra Biomed Holdings Inc (NASDAQ:OBIO) Fits the Minervini High-Growth Momentum Template - ChartMill
Aug Fed Impact: What is Orchestra BioMed Holdings Incs 5 year growth outlook - baoquankhu1.vn
Activity Recap: Does Orchestra BioMed Holdings Inc outperform in volatile markets2026 Market WrapUp & Fast Gain Swing Trade Alerts - baoquankhu1.vn
Analyst Upgrade: How much upside does Orchestra BioMed Holdings Inc have2026 Chart Watch & Free Verified High Yield Trade Plans - baoquankhu1.vn
Orchestra BioMed reports 2025 results, advances pivotal clinical trials - MSN
Orchestra BioMed (NASDAQ: OBIO) insider reports RSU tax withholding event - Stock Titan
Orchestra BioMed (OBIO) officer has shares withheld for RSU tax payment - Stock Titan
Orchestra BioMed (OBIO) insider withholds 32,438 RSU shares for tax - Stock Titan
Stock Report: Does Orchestra BioMed Holdings Inc outperform in volatile markets2026 Opening Moves & Technical Analysis for Trade Confirmation - baoquankhu1.vn
Jefferies cuts Orchestra BioMed stock price target on financing costs By Investing.com - Investing.com Australia
Jefferies cuts Orchestra BioMed stock price target on financing costs - Investing.com
Orchestra BioMed (OBIO) to Release Earnings on Wednesday - MarketBeat
Trend Report: How do insiders feel about Orchestra BioMed Holdings IncRate Cut & Precise Swing Trade Alerts - baoquankhu1.vn
Orchestra BioMed Holdings, Inc. (OBIO) Reports Q2 Loss, Beats Revenue Estimates - MSN
Finanzdaten der Orchestra Biomed Holdings Inc-Aktie (OBIO)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.83%
2.04%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):